METHOD, DEVICE AND SYSTEM FOR TREATMENT OF ADHD
20220304604 · 2022-09-29
Assignee
Inventors
Cpc classification
G16H20/70
PHYSICS
A61B5/1113
HUMAN NECESSITIES
A61B5/165
HUMAN NECESSITIES
A61B5/744
HUMAN NECESSITIES
G16H20/10
PHYSICS
A61B5/4833
HUMAN NECESSITIES
International classification
A61B5/16
HUMAN NECESSITIES
A61B5/00
HUMAN NECESSITIES
Abstract
A system used by a child diagnosed with ADHD and including a wearable device equipped with motion sensors and optionally a location or GPS tracker as a safety feature and using cloud based technology to facilitate the transfer of information among users. Motion data is used for two main purposes: 1) to objectively measure hyperactivity levels on specific metrics and optionally to detect presence or absence of aggression; and 2) to track the child's sleep-wake patterns (given a high percentage of children with ADHD are known to have sleep disorders). Behavior feedback is provided in real time based on the data obtained. Additional sensors may also be used to aid the assessment of child's behavioral functioning and sleep-wake patterns.
Claims
1. A method for the treatment of ADHD, comprising the steps of: providing a wearable device, said wearable device being connectable to an electronic device having an app thereon; defining a plurality of desired behaviors within the app, said behaviors including a plurality of motion based behaviors; defining and creating a plurality of input routines within said app; defining and creating pre-set parameters for generation and presentation of rewards on the wearable device; collecting motion data and/or location data via sensors in the wearable device; analyzing the motion data in the electronic device by an algorithm, comprising the steps of: determining a baseline compliance with the behaviors based on the analyzed motion data; determining deviations from the baseline compliance with the behaviors and routines; comparing the deviations to said pre-set parameters; and presenting a reward based on a positive determination of the deviations.
2. The method of claim 1, further comprising the step of: assigning different levels of deviation required for presentation of the reward.
3. The method of claim 1, further comprising the step of: transmitting the analyzed motion data to a predetermined group of treatment providers.
4. The method of claim 3, wherein the group of treatment providers are selected from the group consisting of: parents, therapists, prescribers, teachers and insurance providers.
5. The method of claim 1, further comprising the step of: reviewing the analyzed motion data over time to determine a compliance level with the input routine and the desired behaviors.
6. The method of claim 5, further comprising: adapting the pre-set parameters based on the review.
7. The method of claim 1, wherein the wearable device includes a display screen to display a pre-selected avatar.
8. The method of claim 7, wherein an appearance of the avatar changes based on the deviations.
9. The method of claim 7, wherein a parent/caregiver views the analysis of motion data in real time and interactively present additional rewards for display on the display screen.
10. A system for the treatment of ADHD, comprising: a wearable device, the wearable device being connectable to an electronic device having an app thereon; the app containing a plurality of desired behaviors including a plurality of motion based behaviors, a plurality of input routines, and pre-set parameters for generation and presentation of rewards on the wearable device; wherein the app collects motion data and/or location data via sensors in the wearable device and analyzes the motion data in the electronic device by an algorithm, comprising the steps of: determining a baseline compliance with the behaviors based on the analyzed motion data; determining deviations from the baseline compliance with said behaviors and routines; comparing said deviations to the pre-set parameters; and a display on the wearable device for presenting a reward based on a positive determination of the deviations.
11. The system of claim 10, further comprising: the app assigning different levels of deviation required for presentation of the reward.
12. The system of claim 10, further comprising: the electronic device transmitting the analyzed motion data to a predetermined group of treatment providers.
13. The system of claim 12, wherein the group of treatment providers are selected from the group consisting of: parents, therapists, prescribers, teachers and insurance providers.
14. The system of claim 10, wherein analyzed motion data is reviewed over time to determine a compliance level with the input routine and said desired behaviors.
15. The system of claim 14, wherein the pre-set parameters are adapted based on said review.
16. The system of claim 10, wherein the display screen displays a pre-selected avatar.
17. The system of claim 16, wherein an appearance of the avatar changes based on the deviations.
18. The system of claim 10, wherein a parent/caregiver views the analysis of motion data in real time and interactively present additional rewards for display on the display screen.
19. The system of claim 10, wherein a provider (therapist or prescriber) views the analysis of motion data and communicates adjustments in treatment to the parent/caregiver.
Description
BRIEF DESCRIPTION OF THE DRAWING FIGURES
[0046] The novel features that are characteristic of the present disclosure are set forth in the appended claims. However, the preferred embodiments, together with further objects and attendant advantages, will be best understood by reference to the following detailed description taken in connection with the accompanying Figures in which:
[0047]
[0048]
[0049]
[0050]
[0051]
[0052]
[0053]
[0054]
[0055]
[0056]
[0057]
[0058]
[0059]
[0060]
DETAILED DESCRIPTION OF THE DISCLOSURE
[0061] The method, device and system of the present disclosure is shown in detail in the attached drawings figures and the detailed discussion below.
[0062] The present disclosure provides a system including a wearable device and using cloud based technology to facilitate the transfer of information allowing parents, therapists and prescribers to track, interpret and implement accurate treatment solutions in real time. The system will be used by a child diagnosed with ADHD. The wearable device in the preferred embodiment is equipped with at least motion sensors. Optionally, the wearable device may also include a location or GPS tracker as a safety feature. Motion data collected by the wearable device is used for two main purposes: 1) to objectively measure hyperactivity levels based on specific metrics (distance, time active, area, micro-events) or other metrics deemed relevant for treatment of ADHD; and 2) to track the child's sleep-wake patterns (given a high percentage of children with ADHD are known to have sleep disorders). Further, the wearable device may detect presence or absence of aggression. Additional sensors may be included to aid the assessment of sleep-wake patterns. Various features of the device, method, and system in accordance with the present disclosure are shown in
[0063] Also, the present invention may employ sensors other than or in addition to motion sensors. For example, heart rate sensors may be used to supplement the amount and type of data collected and increase the sensitivity and accuracy of the present invention.
[0064] Turning to
[0065] The system of the present disclosure as shown at
[0066] In setting up and maintaining the system of the present disclosure during operation, as shown in
[0067] Additionally, the system of the present disclosure may employ a different approach to identifying, tracking and reinforcing child's behavioral functioning in addition to the pre-determined motion based behaviors described above.
[0068] Additionally, in accordance with the disclosure, parents/caregivers preferably create and input routines in the app on the electronic device 12 that generate a schedule 26 for the child 16 as is illustrated at
[0069] As shown in the flow charts of
[0073] Further,
[0074] To add more nuance to the algorithm of the present disclosure and more intensive re-enforcement, different degrees of rewards (e.g., number of points) for different performance level (% change in hyperactivity metrics) may be rewarded. For instance, a 4% change provides 10 points, and a 6% change provides 20 points.
[0075] The pre-set parameters based on which rewards are generated will be contingent on additional factors. The child's age will be one of the contingencies given expected developmental variations of the child's ability for self-control and response to rewards (e.g. younger children may require reinforcements for smaller % changes). Additionally, the algorithm will adapt the parameters (i.e. % change based on which rewards are generated) to the child's sleep quality in a given day reflected by a “sleep score” (determined based on the analysis of sleep data) given the expected possible decline in a child's overall performance in the context of poor sleep. The “sleep score” and specific cut-offs to classify the sleep quality (e.g. normal or mild/moderate/severe sleep impairment) will be determined through proof-of-concept studies. Other contingencies may be considered in algorithm development for example gender, setting (i.e. school or home) among others. Furthermore, the algorithm and specifically the pre-set parameters will be fine-tuned based on population-level performance with growing population data being collected.
[0076] The present disclosure also provides additional consideration for utilization of motion data and other physiological data. For example, machine learning tools (e.g. entropy analysis) will be used to assess impulsivity or inattention (the other core features of ADHD besides hyperactivity) using this wearable. Additionally, similar data analytics tools may be employed to make a determination relative to the presence or absence of aggression which could be part of the ADHD clinical picture. The ability to detect/track those symptoms further strengthens the therapeutic value of the wearable device as they could be included among the target behaviors (e.g. lack of aggression) to be tracked and reinforced.
[0077] The method, device and system of the present disclosure provides for child device interaction. The child 16 wears the wearable device 10 continuously (most of the day and night and across settings) and will be able to access the app (using a child interface) operating on the electronic device 12 and connected to the wearable device 10 on a smartphone or tablet.
[0078] As described at
[0079] The wearable device 10 itself, includes a display 30 where the child 16 can see the Avatar 32 and its changes to an improved Avatar 34. The changes in the Avatar constitute the visual component of the positive reinforcement that is updated immediately following the desired behavior and the Avatar update is delivered autonomously without requiring caregiver firsthand involvement.
[0080] Additionally, the system of the present disclosure may employ a different approach for the visual component of the positive reinforcement other than Avatar if deemed necessary in order to optimize its impact and attend to a diverse patient population.
[0081] The positive reinforcement for the desired behavior has two additional components. The first one entails points earned as calculated by the algorithm. Further points can be entered manually by the parent for the non-motion related goals. The points will be presented as illustrated in
[0082] The second component stems from the parent being able to see in real-time the child's performance (via app interface) and through an interactive feature to be able to send a random reinforcement to the child, such as a “great job” emoji for presentation to the child 16 on the display 30.
[0083] The app interface operating on the electronic device 12 presents to the child 16 the expected daily routines (e.g. morning and night) in form a picture board or another child friendly format.
[0084] The wearable device 10, is connected to the app operating on the electronic device 12 and also may be connected via the electronic device 12 and communications network 14 and integrate with software platforms used by teachers to communicate homework schedule/requirements (e.g. eChalk). This will assist children having ADHD with their planning challenges as part of their executive dysfunction. Additional features in some embodiments may include the device prompting the child to engage in up to 30 min of moderate-vigorous physical activity daily given data showing acute physical exercise to lead to improvement in executive functioning in children with ADHD. This could be a set goal for the child with its completion being determined by tracking motion data. Further, integration with exergaming can facilitate the child's engagement in a moderate-vigorous physical activity.
[0085] The method, device and system of the present disclosure also provides a unique parent-device interactivity, as seen in
[0086] The parent will be able to see the child's performance on the motion based goals both in real time and at the end of the day/week/month. In this context, the parent will be able to reinforce the child both in real time through the interactive feature (e.g. sending “great job” emoji) and at the end of the day/week/month. The parent will input manually points for the non-motion based goals (e.g. medication compliance).
[0087] Therapist 20 and prescriber 22 interaction is also provided with the present disclosure, as seen in
[0088] Other users may interact with the method and system of the present disclosure. The growing customer base coupled with the long-term use of the wearable device will allow for de-identified and privacy compliant data collection including motion and sleep data (and other sensor data), medication choices/dosage/compliance, treatment response and demographics. The accumulated data provides a valuable platform for multiple uses such as 1) Clinical/treatment research including but not limited to the use of predictive analytics to identify determinants of treatment response or risk factors for treatment resistance; and 2) pharmaceutical companies could utilize this platform and the device to aid their clinical trials for drug development including dosage optimization. Currently, drug efficacy during clinical trials is determined by using questionnaires administered either by a clinical investigator (e.g. ADHD Rating Scale (ADHD-RS), Clinical Global Impression-Improvement (CGI-I) rating scale) or by the parent (Conners' Parent Rating Scale). While those questionnaires are standardized tools, they add a level of subjectivity and are also labor/staff intensive therefore costly. For instance, ADHD Rating Scale (ADHD-RS) is an 18-item questionnaire with a score range of 0-54 points that measures the core symptoms of ADHD which includes both hyperactive/impulsive and inattentive subscales, and 3) Insurance companies could also utilize the platform to identify through data analytics optimized treatment protocols and aid in their population health management, as in
[0089] It should be understood that the invention herein is not limited to the treatment of ADHD. The same principles, tools, methods, devices and system of the present invention can be used for treating other health issues, such as other disruptive behavior disorders, obesity, depression, and the like.
[0090] While there is shown and described herein certain specific structure embodying the disclosure, it will be manifest to those skilled in the art that various modifications and rearrangements of the parts may be made without departing from the spirit and scope of the underlying inventive concept and that the same is not limited to the particular forms herein shown and described except insofar as indicated by the scope of the appended claims.